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602Objectives: Bicuspid aortic valve is frequently associated with underlying aortopathy. Data support an aggres-
sive approach to replacement of the ascending aorta. However, the natural history of the unreplaced aortic arch is
unknown, and some have advocated routine replacement of the proximal arch in this setting.
Methods: We identified patients with bicuspid aortic valve undergoing repair or replacement of the ascending
aorta with or without aortic valve replacement or root replacement between January1988 and December 2007 at
our institution. Follow-up was by review of clinical records and postal questionnaire.
Results: Of 470 patients identified, 48 patients had hemiarch or total arch replacement and were excluded. Of
the remaining 422 patients, 227 had separate aortic valve replacement or repair and ascending aortoplasty (76) or
ascending aortic graft replacement (175), 107 a valved conduit, 40 a homograft root, and 21 a valve-sparing root
replacement. The mean age was 56 15 years, and 80%were male. Follow-up was up to 17 (median 4.2) years.
There were 23 (5.5%) late reoperations, of which none were for arch dilatation. Survival at 1, 5, 10, and 12 years
was 96.5%, 89.6%, 77.7%, and 74.0%. Freedom from late reoperation was 98.7%, 94.1%, 81.0%, and 81.0%.
Paired echocardiographic measurements of aortic arch diameter (n ¼ 58) were 33.3 mm preoperatively versus
31.9 mm postoperatively (P ¼ .135) at a mean 4 years.
Conclusions: Progressive dilatation of the aortic arch leading to reoperation after repair of ascending aortic
aneurysm in patients with bicuspid aortic valve is uncommon. A selective approach to transverse aortic arch
replacement is appropriate. (J Thorac Cardiovasc Surg 2011;142:602-7)Bicuspid aortic valve (BAV) is the most common congenital
cardiac malformation, occurring in 1% to 2% of the popu-
lation.1 BAV is associated with a variety of vascular abnor-
malities, such as aortic dilatation, coarctation of the aorta,
interrupted aortic arch, anomalous coronary ostium, and pat-
ent ductus arteriosus, of which enlargement of the ascending
aorta is themost common.2-5 These observations support the
concept of an inherited, generalized aortopathy.6 Further-
more, an increasingly aggressive approach to ascending aor-
tic replacement is advocated given clinical evidence of
significant need for reoperation when even an only moder-
ately dilated ascending aorta is left behind at the time of aor-
tic valve replacement (AVR).1,7,8
On the basis of these observations, as well as imaging
analyses that suggest extension of the enlargement into
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The Journal of Thoracic and Cardiovascular Surgfor almost routine hemiarch replacement in the setting of
BAV.9 Despite improvements in techniques for aortic arch
procedures with low operative morbidity and mortality in
the current era, the operative risk remains higher than
that of isolated ascending aortic surgery.10 The added com-
plexity and risk associated with arch replacement is only
justifiable if the incidence of clinically relevant progressive
aortic arch dilatation leads to reoperation, however. We
therefore examined our experience with the treatment of
aneurysmal disease of the ascending aorta without arch re-
placement to determine the late incidence of reoperation for
arch disease.METHODS
After approval by the Mayo Clinic Rochester Institutional Review
Board with waiver of study-specific consent, we searched our computer-
ized Society of Thoracic Surgeons–compliant clinical database for patients
who had undergone intervention on an aneurysmal ascending aorta associ-
ated with a BAV between January 1, 1988, and December 31, 2007. Pa-
tients denying consent for inclusion in research studies were excluded, as
were those with known Marfan syndrome or Ehlers–Danlos syndrome.
We reviewed the electronicmedical record including echocardiographic re-
ports, pathologic reports, and all operative records. Among those with
paired studies, aortic arch dimensions were determined from preoperative
and most recent (>3 months) postoperative echocardiography.
Follow-up
Follow-up information was obtained by chart review and cardiothoracic
questionnaire survey. Maximum follow-up period was extended to 17.2
years and median was 4.2 years.ery c September 2011
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BAV ¼ bicuspid aortic valve
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Park et al Acquired Cardiovascular DiseaseStatistical Analysis
Continuous variables were described as mean standard deviation and
categorical variables were expressed as percentage and frequency. Preoper-
ative and postoperative aortic arch dimension was compared by paired t
test. Long-term survival and freedom from reoperation were studied by
the the Kaplan–Meier method. Log–rank test was used for comparison be-
tween groups according to surgical procedure or risk factor. Cox regression
models were used to identify the univariate and multivariate predictors of
overall survival. The SAS system (SAS Institute Inc, Cary, NC) was used
for all analyses.A
C
DRESULTS
Patient Demographics
A total of 470 patients undergoing ascending aortic re-
placement for BAV-associated aneurysms were identified
during the study interval. Of these, 48 patients underwent
hemiarch or total arch replacement and were excluded.
Among the 422 patients included in this study, men predo-
minated (79.6%) and the mean age of the patients at the ini-
tial operation was 55.8 14.9 years, with a range from 20 to
86 years (Table 1). Of these, 30 (7%) patients had a history
of aortic coarctation. The dominant functional aortic valve
disease was stenosis in 49.5% and insufficiency in 43.6%
(Table 2).The mean ascending aortic diameter was only
50.6 8.1 mm at the time of surgery; however, the majority
of patients (374/422, 89%) had concomitant valve repair or
replacement, making it difficult to tell in retrospect which
pathologic condition was considered by the surgeon to be
the primary driver for intervention. Five patients had acute
dissection as their primary indication for surgery.Operative Characteristics
Separate AVR and graft replacement of the ascending
aorta or aortoplasty was performed in 227 (54%) patients
and composite valve graft replacement in 107 (25%) pa-
tients (Table 3). The most common concomitant procedure
was coronary artery bypass grafting (15%). In 33 (7.8%)
patients, at the preference of the operating surgeon, the dis-
tal anastomosis was performed open under circulatory ar-
rest at the level of innominate artery origin to achieve
complete ascending aortic replacement without true hemi-
arch replacement. Among those 33 undergoing the distal
anastomosis open under circulatory arrest, the mean aortic
arch diameter was slightly larger at 36.3  8.0 mm than
that for the 389 in whom the distal anastomosis was
performed with a crossclamp in place at 33.7  6.0 mm.
The corresponding ascending aortic diameters wereThe Journal of Thoracic and Ca55.2  6.6 mm and 50.2  8.1 mm for open versus cross-
clamp technique.
There were 7 (1.7%) perioperative deaths and operative
mortality was similar regardless of the procedure
(P ¼ .42). In 5 cases the indication for surgery was acute
dissection; 3 of these patients did not survive their hospital-
ization. Thirty-two (7.8%) patients underwent reoperation
for bleeding. Postoperative intra-aortic balloon pump sup-
port was used in 12 (2.9%) patients, and 31 (8.2%) patients
required prolonged ventilation. Three (0.7%) patients had
transient ischemic attacks and 7 (1.7%) permanent stroke.
Seven (1.9%) patients had postoperative renal failure,
3 (0.7%) had sepsis, and 1 (0.2%) had multiorgan failure.
Late Outcomes
During follow-up, 52 patients died. There were no deaths
known to be due to aortic dissection or rupture, although the
cause of death was unknown in 28 patients. The causes of
death were cardiac in 15.4%, noncardiac in 30.8%, and un-
known in 53.8%. Cox regression model analysis showed
age (hazard ratio [HR], 1.1; P< .001), diabetes mellitus
(HR, 4.2; P< .001), preoperative renal failure (HR, 7.9;
P<.001), and New York Heart Association functional class
III/IV (HR, 2.6; P< .003) as independent predictors for
overall death. Overall survival at 1, 5, 10, and 12 years
was 96.5%, 89.6%, 77.7%, and 74%, respectively
(Figure 1). Predictors of late death by multivariate analysis
included age, diabetes mellitus, preoperative renal failure,
New York Heart Association functional class III or IV,
and acute dissection (Table 4).
Reoperations occurred in 23 (5.5%) patients, none of
whom had had arch surgery (Table 5). The average interval
between the first operation and reoperation was 5.8 years,
and the most common indication for reoperative surgery
was endocarditis (7 patients). Four patients underwent reop-
eration for ascending aortic dilatation at a mean of 9.7 years
(range, 8.1–12.3 years) after ascending aortic aortoplasty. A
67-year-old man who had undergone AVR for aortic steno-
sis, ascending reduction aortoplasty, and coronary artery
bypass grafting underwent graft replacement of the ascend-
ing aorta and root 9 years later for enlargement of the aortic
root and ascending aorta. A 53-year-old male patient who
had undergone aortic valve repair and aortoplasty required
first reoperation for AVR 1 year later for aortic regurgitation
and again 11 years later for aortic root and ascending aorta
replacement. A 40-year-old man who had undergone AVR
and ascending aortoplasty required AVR and graft replace-
ment of the ascending aorta 9 years later because of patient–
prosthesis mismatch with redilation of the ascending aorta
incidentally noted. A 24-year-old woman who had under-
gone homograft AVR required reoperation for dilated distal
native ascending aorta 8 years later. In summary, 4 (17%) of
23 reoperations were primarily for aorta-related problems,
including 4 (5.3%) ascending aortic reoperations amongrdiovascular Surgery c Volume 142, Number 3 603
TABLE 3. Operative characteristics
Variable Frequency
ACC time (min) 78.5  33.8
CPB time (min) 107.3  48.9
Circulatory arrest time (min) 18.6  10.8
Operative procedures
Separate AVR/graft replacement, no. 156 (37.0%)
Separate AVR/aortoplasty, no. 71 (16.8%)
Valved conduit, no. 107 (25.4%)
Homograft, no. 40 (9.5%)
Valve-sparing root replacement, no. 21 (5.0%)
AV repair/graft replacement, no. 19 (4.5%)
AV repair/aortoplasty, no. 5 (1.2%)
Concomitant procedure
CABG, no. 64 (15.2%)
MV procedure, no. 8 (1.9%)
TV procedure, no. 6 (1.4%)
PV procedure, no. 3 (0.7%)
Type of valve
Mechanical, no. 209 (55.9%)
Bioprosthetic, no. 125 (33.4%)
Homograft, no. 40 (10.7%)
ACC, Aortic crossclamp; CPB, cardiopulmonary bypass; AVR, aortic valve replace-
ment; AV, aortic valve; CABG, coronary artery bypass grafting; MV, mitral valve;
TV, tricuspid valve; PV, pulmonary valve.
TABLE 1. Preoperative data
Variable Frequency
Age (y) 55.8  14.9
Sex (male), no. 336 (79.6%)
Tobacco abuse, no. 194 (50.3%)
Diabetes mellitus, no. 35 (9.0%)
Hypercholesterolemia, no. 213 (55.5%)
Renal failure, no. 8 (1.9%)
Hypertension, no. 205 (53.2%)
Cerebrovascular accident, no. 12 (2.9%)
Peripheral vascular disease, no. 37 (9.7%)
NYHA (III/IV), no. 134 (35.7%)
Coronary artery disease, no. 99 (23.7%)
History of coarctation of aorta, no. 30 (7.3%)
NYHA, New York Heart Association.
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D76 patients undergoing aortoplasty. When considered
conversely, among the 23 patients undergoing reoperation,
7 (30%) had undergone aortoplasty at their initial opera-
tion, although not all were for aortic complications. The
probability of freedom from late reoperation at 1, 5, 10,
and 12 years was 98.7%, 94.1%, 81.0%, and 81.0%,
respectively (Figure 2).Comparison of Aortic Arch Dimensions
Preoperatively, the dimensions of the aortic root were
26.3 mm at the annulus, 42.7 mm at the sinuses of Valsalva,
and 36.8 mm at the sinotubular junction; dimension of the
ascending aorta was 50.6 mm. Peroperative measures of
the aortic arch diameter were available in 199 (47.2%) pa-
tients. The median diameter was 33.9 mmwith a range from
19 to 51 mm. As shown in Figure 3, 58% of these were be-
tween 30 and 39 mm and 18% were 40 mm or larger.
Among 395 patients having postoperative echocardio-
grams, 58 patients had data sufficient for paired measure-
ment of aortic arch dimensions. The average dimension ofTABLE 2. Preoperative echocardiographic findings
Variable Frequency
Dominance of AV disease
Aortic stenosis, no. 209 (49.5%)
Aortic insufficiency, no. 184 (43.6%)
Mixed, no. 29 (6.9%)
EF (%) 59.8  11.0
Sizes of aortic root
Annulus (mm) 26.3  4.4
Sinuses of Valsalva (mm) 42.7  7.6
Sinotubular junction (mm) 36.8  6.5
Sizes of aorta
Ascending aorta (mm) 50.6  8.1
Arch (mm) 33.9  6.2
Descending aorta (mm) 23.5  6.4
AV, Aortic valve; EF, ejection fraction.
604 The Journal of Thoracic and Cardiovascular Surgthe aortic arch (Figure 4) was unchanged at 4 years postop-
eratively (mean, 31.9  5.4 mm) compared with preopera-
tively (mean, 33.3  6.2 mm). Among 8 patients whose
aortic arch was measured at 4 cm or greater (42.6  2.3
mm), at a mean follow-up of 4.6  2.9 years the mean
arch diameter was actually reduced at 35.6  6.4 mm
(P ¼ .027), perhaps secondary to changes in proximal
arch geometry owing to the distal anastomosis. None of
these arches reached threshold for reoperation.DISCUSSION
The findings of this study demonstrate that, despite con-
cerns about a generalized aortopathy associated with BAV,
reoperation for aortic arch dilatation after replacement or
repair of the ascending aorta alone is uncommon. This is
not to say that arch replacement is never necessary, inas-
much as arch replacement was undertaken in approximately
10% of patients during the study interval. It may well be
that our observation that late reoperation for arch replace-
ment is, at a minimum, uncommonly necessary is a reflec-
tion of accurate identification of the patients at risk by the
operating surgeon, and that progressive dilatation was obvi-
ated by appropriate surgical intervention. The data suggest,
however, that if the arch does not meet clinical threshold for
replacement at the time of ascending aortic replacement, it
is unlikely to progressively dilate to a point requiring reop-
eration. Furthermore, although serial arch measurements
are available only in a small percentage of cases, and
some instances of dilatation may have gone unrecognized,ery c September 2011
FIGURE 1. Overall survival of 422 patients undergoing repair or replace-
ment of the ascending aorta for bicuspid aortic valve disease and ascending
aortic aneurysm.
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ity associated with the condition. Finally, aortoplasty as op-
posed to graft replacement of the aorta appears to leave
patients at risk for reoperation; this procedure is rarely prac-
ticed in our institution currently.
Previous clinical studies have focused principally on di-
latation of the ascending aorta in association with BAV2-5
even independent of functional valve pathology11-13 and
the risk of reoperation, dissection, or sudden death.7,8,14,15
Inasmuch as there is ample evidence from pedigree
studies of a genetic basis to BAV, and histologic
abnormalities have been identified in the media of the
ascending aorta in patients with BAV, it is reasonable to
suspect that, at least in a subset of patients, aortic
dilatation or aneurysm formation may also extend to the
transverse aortic arch.9 Magnetic resonance angiography
has suggested associated dilatation of the entire thoracic
aorta in patients with BAV,4 and cluster analysis has demon-
strated involvement of the proximal aortic arch in 73% of
individuals with BAV with extension into the mid-arch in
35%.9 Evidence of the clinical relevance of this findingTABLE 4. Univariate and multivariate analysis for overall survival
Univariate
HR CI
Age 1.1 1.04–1.1
DM 4.4 2.29–8.55
Preop RF 5.2 1.86–14.51
History of CVA 3.5 1.4–8.96
PVD 2.2 1.16–4.26
NYHA (III/IV) 3.2 1.76–5.87
CAD 3.3 1.86–5.68
Current CABG 3.1 1.75–5.43
LV dysfunction (EF  40%) 2.6 1.17–5.89
Acute dissection 21 7.29–59.52
HR, Hazard ratio; CI, confidence interval; DM, diabetes mellitus; RF, renal failure; CVA,
Association; CAD, coronary artery disease; CABG, coronary artery bypass grafting; LV, le
The Journal of Thoracic and Caas manifest by surgically relevant late aneurysm formation,
however, is not clear. In our patients with BAVand ascend-
ing aortic aneurysm, only 10% of patients underwent arch
intervention, and another 18% of patients showed dilated
aortic arch (40 mm). In contrast to findings reported pre-
viously by others pertinent to the unreplaced ascending
aorta,8,16 however, reoperation was not observed.
Our findings are consistent with a prior community-based
study reporting no significant difference between the BAV
and control groups with respect to dimensions of the aortic
arch,14 and another recent magnetic resonance imaging
study that revealed no differences in the mean diameters
of the aortic arch.17 Correlation between age and the dimen-
sion of the aortic arch was suggested by Cecconi and asso-
ciates,18 and significant increases in the dimensions of the
aortic arch were predominantly found in patients over 40
years of age. Admittedly, these are cross-sectional studies,
and not longitudinal.
It is likely that the aortopathy associated with BAV is het-
erogeneous as suggested by Della Corte and colleagues19
and that aneurysm formation is multifactorial, with hemo-
dynamic effects superimposed on underlying abnormality
of the connective tissue leading to phenotypic variability.
Accordingly, it would not be surprising if the arch behaved
differently from the ascending aorta given differences in he-
modynamic forces. Dissection tears less often begin in the
arch, and arch aneurysms of all etiologies are less common
than aneurysms of either the ascending or descending tho-
racic aorta. Among patients with BAV, the largest aortic di-
ameter is in the ascending segment. With a baseline smaller
diameter, the aortic arch might be expected to dilate less
rapidly given lower wall tension by the law of LaPlace
and clinical evidence from patients with ascending aortic
dilatation of a lower incidence of late aortic dilation among
those without baseline dilatation than those with larger
diameter.19,20
We do not advocate ignoring arch dilatation that exists at
the time of ascending aortic replacement. In the study ofMultivariate
P value HR CI P value
<.001 1.1 1.03–1.09 <.001
<.001 3.8 1.87–7.89 <.001
.002 8.3 2.85–23.78 <.001
.008
.016
<.001 2.3 1.25–4.35 .008
<.001
<.001
.019
<.001 6.9 2–23.60 .002
cerebrovascular accident; PVD, peripheral vascular disease; NYHA, New York Heart
ft ventricle; EF, ejection fraction.
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TABLE 5. Indications for reoperations
Indication No.
Aorta related
Aortic root/ascending aortic dilatation 2
Ascending aortic dilatation 2
AV related
Endocarditis 7
Prosthetic valve 5
Homograft 1
Native valve 1
PPM 2
Native AV disease 2
Periprosthetic leakage 1
Other 3
AV, Aortic valve; PPM, patient–prosthesis mismatching.
0
5
10
15
20
25
30
I
n
c
i
d
e
n
c
e
 
(
%
)
≤19 20-24 25-29 30-34 35-39 40-44 45-49 ≥50
Arch size (mm)
FIGURE 3. Distribution of aortic arch size at the time of operation.
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D206patientswithBAVundergoing root replacement reported
byEtz and associates,21 38% of patients underwent concom-
itant arch surgery, including hemiarch and total arch replace-
ment. Three patients required late reoperation for aortic arch
surgery, including 1 patient who had progressive arch dila-
tion 6 years after hemiarch replacement. There were no
late reoperations for the arch among the patients undergoing
isolated ascending aortic surgery, perhaps demonstrating
good clinical judgment with regard to who might progress.
They also found that there were no significant increases in
the growth rates of the distal aortic arch during 5 years’
follow-up. In their study of BAV disease with longer
follow-up to a mean of 20 years, Russo and associates17
found 3 reoperations for late ascending aortic aneurysm
but no late procedures involving the aortic arch.Although to-
tal arch replacement is performed with low morbidity and
mortality in experienced centers22-23 and some groups
recommend extensive aortic arch replacement in BAV
patients with ascending aortic dilatation,9 in most centers
aortic arch surgery still carries some increment of excess
risk of morbidity andmortality(3% vs 9%).10 Therefore, re-
placement of the aortic arch should not be undertaken lightly.FIGURE 2. Freedom from late reoperation after repair of ascending aortic
aneurysm and bicuspid aortic valve disease.
606 The Journal of Thoracic and Cardiovascular SurgOur study has limitations. It is a retrospective study
heavily dependent on the details provided in the medical
record. Paired comparisons of aortic arch size were avail-
able in only 14% of patients, inasmuch as aortic measure-
ments were not performed routinely in the past in our
echocardiography laboratory. Inconsistency in criteria for
arch replacement among the numerous surgeons involved
in the study may also be cited as a weakness and certainly
makes it difficult to establish threshold criteria for arch sur-
gery. Conversely, we would argue that this diversity also
supports the generalizability of the results.
In conclusion, hemiarch or total arch replacement need
not be performed routinely when replacing the ascending
aorta for BAV-associated ascending aortic dilatation. To
do so would potentially expose a large percentage of
patients unnecessarily to a more extensive procedure with
associated perfusion complexity required for arch interven-
tion. It is our current practice to tailor the procedure to the
patient, being more aggressive in those patients younger
than 50 years of age and more conservative in those overFIGURE 4. Change of size in aortic arch at a mean of 4 years postopera-
tively.
ery c September 2011
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Dthe age of 70, but generally performing hemiarch replace-
ment if the proximal arch exceeds 4 cm in diameter.
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